The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
复制标题
DOI：
10.1016/j.jsat.2020.108163
复制
发表时间：
2021-01
影响因子：
3.9
通讯作者：
Pantalone DW
中科院分区：
文献类型：
--
作者：
Hughto JMW;Peterson L;Perry NS;Donoyan A;Mimiaga MJ;Nelson KM;Pantalone DW
从历史上看，联邦和州政策对治疗模式的定义很窄，导致接受阿片类药物使用障碍（MOUD;例如，美沙酮和丁丙诺啡）。为应对新型冠状病毒大流行，门诊MOUD治疗提供者迅速从传统的面对面护理模式过渡到修订的COVID-19协议，优先考虑远程健康咨询，以保护患者和员工的健康，并确保MOUD护理的连续性。这些远程医疗创新似乎减轻了传统系统中咨询的许多长期障碍，并有可能永远改变MOUD护理服务。从罗德岛的诊所的数据，我们认为，MOUD咨询是可以通过远程医疗实现的，并概述了需要，和预期的好处，混合远程医疗/在人MOUD治疗模式向前发展。
Historically, federal and state policies have narrowly defined treatment models that have resulted in limited access to and engagement in counseling for individuals receiving medications for opioid use disorder (MOUD; e.g., methadone and buprenorphine). In response to the coronavirus pandemic, outpatient MOUD treatment providers rapidly transitioned from traditional, in-person care delivery models to revised COVID-19 protocols that prioritized telehealth counseling to protect the health of patients and staff and ensure continuity in MOUD care. These telehealth innovations appear to mitigate many of the longstanding barriers to counseling in the traditional system and have the potential to forever alter MOUD care delivery. Drawing on data from a Rhode Island–based clinic, we argue that MOUD counseling is achievable via telehealth and outline the need for, and anticipated benefits of, hybrid telehealth/in-person MOUD treatment models moving forward.
登录
查看更多内容
影响因子：
2.3
作者：
Fonner, Kathryn L.;Roloff, Michael E.
通讯作者：
Roloff, Michael E.
影响因子：
5.5
作者：
Zheng, Wanhong;Nickasch, Michael;Sullivan, Carl
通讯作者：
Sullivan, Carl
影响因子：
4.2
作者：
Eibl, Joseph K.;Gauthier, Graham;Marsh, David C.
通讯作者：
Marsh, David C.
影响因子：
3.9
作者：
Uscher-Pines, Lori;Raja, Pushpa;Huskamp, Haiden A.
通讯作者：
Huskamp, Haiden A.
影响因子：
5.5
作者：
Kampman K;Jarvis M
通讯作者：
Jarvis M